"Factor Xa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.
| Descriptor ID |
D015951
|
| MeSH Number(s) |
D08.811.277.656.300.760.315 D08.811.277.656.959.350.315 D12.776.124.125.400.315 D23.119.400.315
|
| Concept/Terms |
Factor Xa- Factor Xa
- Factor Ten A
- Activated Factor X
- Factor X, Activated
- Coagulation Factor Xa
- Factor Xa, Coagulation
- Blood Coagulation Factor X, Activated
- Thrombokinase
- Factor 10A
- Autoprothrombin C
|
Below are MeSH descriptors whose meaning is more general than "Factor Xa".
Below are MeSH descriptors whose meaning is more specific than "Factor Xa".
This graph shows the total number of publications written about "Factor Xa" by people in this website by year, and whether "Factor Xa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Factor Xa" by people in Profiles.
-
Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations. Pharmacotherapy. 2022 10; 42(10):768-779.
-
Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation. Sci Rep. 2021 11 08; 11(1):21852.
-
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants. Pharmacol Res. 2019 07; 145:104257.
-
Throwing it in reverse: An update on reversal of oral factor Xa inhibitors. Am J Emerg Med. 2019 10; 37(10):1978-1980.
-
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
-
Hookworm infection. Nat Rev Dis Primers. 2016 12 08; 2:16088.
-
Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients. Ann Pharmacother. 2016 10; 50(10):824-31.
-
The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. J Neurosurg Pediatr. 2015 Sep; 16(3):329-34.
-
Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med. 2014 Feb; 15(2):178-9.
-
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.